Literature DB >> 24237110

Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

E Taraldsrud1, B Fevang, P Aukrust, K H Beiske, Y Fløisand, S Frøland, H Rollag, J Olweus.   

Abstract

Patients with common variable immunodeficiency (CVID) have reduced numbers and frequencies of dendritic cells (DCs) in blood, and there is also evidence for defective activation through Toll-like receptors (TLRs). Collectively, these observations may point to a primary defect in the generation of functional DCs. Here, we measured frequencies of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) in peripheral blood of 26 CVID patients and 16 healthy controls. The results show that the patients have reduced absolute counts of both subsets. However, the decreased numbers in peripheral blood were not reflected in reduced frequencies of CD34(+) pDC progenitors in the bone marrow. Moreover, studies at the single cell level showed that DCs from CVID patients and healthy controls produced similar amounts of interferon-α or interleukin-12 and expressed similar levels of activation markers in response to human cytomegalovirus and ligands for TLR-7 and TLR-9. The study represents the most thorough functional characterization to date, and the first to assess bone marrow progenitor output, of naturally occurring DCs in CVID. In conclusion, it seems unlikely that CVID is secondary to insufficient production of naturally occurring DCs or a defect in their signalling through TLR-7 or TLR-9.
© 2013 British Society for Immunology.

Entities:  

Keywords:  IFN-α; TLR-9; bone marrow; common variable immunodeficiency; plasmacytoid dendritic cell

Mesh:

Substances:

Year:  2014        PMID: 24237110      PMCID: PMC3927904          DOI: 10.1111/cei.12239

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Authors:  N Martinez-Pomar; S Raga; J Ferrer; J Pons; I Munoz-Saa; M-R Julia; J de Gracia; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Quantitative and functional evaluation of innate immune responses in patients with common variable immunodeficiency.

Authors:  C M Trujillo; C Muskus; J Arango; P J Patiño; C J Montoya
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

4.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Defective maturation of dendritic cells in common variable immunodeficiency.

Authors:  T H Scott-Taylor; M R Green; M Raeiszadeh; S Workman; A D Webster
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

Review 6.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

7.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Authors:  H Donaghy; A Pozniak; B Gazzard; N Qazi; J Gilmour; F Gotch; S Patterson
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

Authors:  Lorant Farkas; Espen O Kvale; Finn-Eirik Johansen; Frode L Jahnsen; Fridtjof Lund-Johansen
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

9.  Altered dendritic cell distribution in patients with common variable immunodeficiency.

Authors:  Jean-François Viallard; Fabrice Camou; Marc André; François Liferman; Jean-François Moreau; Jean-Luc Pellegrin; Patrick Blanco
Journal:  Arthritis Res Ther       Date:  2005-07-01       Impact factor: 5.156

10.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  6 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

Review 2.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 4.  Common Variable Immunodeficiency.

Authors:  Biman Saikia; Sudhir Gupta
Journal:  Indian J Pediatr       Date:  2016-02-12       Impact factor: 1.967

Review 5.  Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

Authors:  Sanchi Chawla; Prabal Barman; Rahul Tyagi; Ankur Kumar Jindal; Saniya Sharma; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 6.  Common Variable Immunodeficiency and Gastric Malignancies.

Authors:  Patrizia Leone; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.